NYSE:EFC
NYSE:EFCMortgage REITs

Ellington Financial (EFC): Reassessing Valuation After a Year of Strong Total Shareholder Returns

Ellington Financial (EFC) has been quietly rewarding patient shareholders, and its recent run of steady returns is drawing fresh attention. With income, credit, and housing all in focus, investors are reassessing what comes next. See our latest analysis for Ellington Financial. After a solid year where Ellington Financial’s share price has climbed from income play to quiet outperformer, its recent 11.92% year to date share price return and 25.03% one year total shareholder return signal that...
NYSE:W
NYSE:WSpecialty Retail

Is Wayfair's (W) Cyber Week Discount Blitz Reframing Its Path to Sustainable Scale?

Wayfair recently ran a Cyber Week Sale featuring steep discounts across furniture, décor, housewares, and home improvement items, including branded collections like Magnolia Homes by Joanna Gaines, to draw holiday shoppers. By concentrating major promotions on big-ticket home goods at the peak of holiday demand, Wayfair is testing how deep discounting can influence customer engagement and order volumes. Next, we’ll examine how Wayfair’s aggressive Cyber Week discounting across core home...
NYSE:AFG
NYSE:AFGInsurance

Assessing American Financial Group’s Valuation After Expanded Share Repurchase Authorization Through 2030

American Financial Group (AFG) just expanded its share repurchase authorization by 5 million shares and extended the program to 2030, a shareholder-friendly move that tightens supply and underscores management confidence. See our latest analysis for American Financial Group. Despite the fresh buyback news, American Financial Group’s recent share price performance has been subdued, with a 30 day share price return of minus 7.47 percent and a one year total shareholder return of minus 1.52...
NasdaqGS:BPOP
NasdaqGS:BPOPBanks

Popular (BPOP) Valuation Check After This Year’s 26% Share Price Gain

Popular (BPOP) has quietly rewarded patient shareholders, with the stock up about 26% this year even after some pullback in the past 3 months. This invites a closer look at what is driving returns. See our latest analysis for Popular. With the share price now around $116.90, Popular’s solid year to date share price return and strong multi year total shareholder returns suggest momentum is cooling a little rather than reversing, as investors reassess both growth prospects and risk. If...
NYSE:SKT
NYSE:SKTRetail REITs

Tanger (SKT): Assessing Valuation After Recent Share Price Pullback

Tanger (SKT) has quietly slipped about 7% over the past month, even as its long term track record remains strong, so the stock now looks interesting for income focused investors watching retail real estate. See our latest analysis for Tanger. That pullback sits against a year to date share price return of around negative mid single digits and a one year total shareholder return of negative high single digits. However, the three and five year total shareholder returns remain very strong, which...
NasdaqGS:MRVL
NasdaqGS:MRVLSemiconductor

The Bull Case For Marvell Technology (MRVL) Could Change Following Amazon AI Shift And Celestial AI Deal

In early December 2025, Marvell Technology reported a jump in third-quarter revenue to US$2,074.5 million and swung from a net loss to net income of US$1,901.3 million, issued guidance for fourth-quarter revenue of about US$2.20 billion, and was reported to be in advanced talks to acquire photonics startup Celestial AI in a multi‑billion‑dollar cash‑and‑stock deal. At the same time, fresh concerns about Marvell potentially losing Amazon’s next‑generation Trainium AI chip designs to a rival,...
NasdaqGS:PANW
NasdaqGS:PANWSoftware

What Palo Alto Networks (PANW)'s Defense of Its Classified Board Means For Shareholders

On December 1, 2025, Palo Alto Networks issued a presentation urging shareholders to support its classified Board structure, arguing that staggered director terms enhance continuity, institutional knowledge, and long-term execution on priorities like large acquisitions and adapting to generative AI, while remaining consistent with Delaware fiduciary duties. The company’s push to retain a classified Board highlights a tension between management’s preference for stability and some investors’...
NasdaqGS:TERN
NasdaqGS:TERNPharmaceuticals

Terns Pharmaceuticals (TERN): Evaluating Rich Valuation After CARDINAL Trial Update and 2025 ASH Presentation

Terns Pharmaceuticals (TERN) is back on radar after updated data from its CARDINAL trial of TERN-701 in previously treated chronic myeloid leukemia was highlighted in an oral session at the 2025 ASH meeting. See our latest analysis for Terns Pharmaceuticals. The ASH spotlight has clearly intensified interest in Terns, with a 1 month share price return of 117.81 percent and a 90 day share price return of 432.85 percent helping drive a powerful year to date surge. At the same time, a 3 year...
NYSE:GRC
NYSE:GRCMachinery

How Investors Are Reacting To Gorman-Rupp (GRC) Analyst Upgrades And A Consensus Buy Rating

In recent days, Gorman-Rupp received an upgrade from Wall Street Zen to a “buy” rating, while Weiss Ratings reiterated its “buy (b)” view, giving the pump manufacturer a consensus “Buy” rating according to MarketBeat.com. This cluster of positive analyst opinions highlights growing confidence in Gorman-Rupp’s business quality and may draw fresh attention from institutional and retail investors alike. With these analyst upgrades spotlighting renewed confidence in Gorman-Rupp, we’ll now...
NasdaqGM:TNDM
NasdaqGM:TNDMMedical Equipment

Did Tandem’s Insulin Pump Correction and Securities Probe Just Shift Tandem Diabetes Care's (TNDM) Investment Narrative?

In August 2025, Tandem Diabetes Care issued a voluntary medical device correction for select t:slim X2 insulin pumps after identifying a potential speaker-related fault that could interrupt insulin delivery, and this has since drawn scrutiny as of December 2025. The correction has triggered investigations by law firms into whether the company provided materially misleading information to investors, raising fresh questions about its disclosure and product-risk management practices. We’ll now...
NYSE:AB
NYSE:ABCapital Markets

Assessing AllianceBernstein (AB) Valuation After Its 26% One-Year Shareholder Return

AllianceBernstein Holding (AB) has quietly outperformed the market over the past year, with the stock up about 26% and nearly doubling over five years. This performance is prompting a closer look at what still drives upside. See our latest analysis for AllianceBernstein Holding. With the share price at $41.88, AB has added a solid 7.0% 1 month share price return, and its 1 year total shareholder return near 26% hints that momentum is still tilting in shareholders' favor rather than fading. If...
NYSE:DDS
NYSE:DDSMultiline Retail

The Bull Case For Dillard's (DDS) Could Change Following Mixed Results And Exclusive-Brand Margin Strength

Dillard’s recently reported higher net sales and net income, underscoring financial resilience even as its construction segment saw reduced activity and performance obligations. A key differentiator emerging from the update is Dillard’s emphasis on exclusive brand merchandise, which is helping support retail gross margins amid sector pressures. We’ll now examine how this focus on exclusive brands shapes Dillard’s investment narrative, particularly in light of its mixed segment...
NYSE:WRBY
NYSE:WRBYSpecialty Retail

Warby Parker (WRBY): Valuation Check After 2026 AI Smart Glasses Partnership With Google

Warby Parker (WRBY) shares pushed higher after Google used The Android Show XR Edition to confirm their jointly developed AI smart glasses are targeting a 2026 launch, spotlighting Warby Parker’s entry into connected eyewear. See our latest analysis for Warby Parker. The 13.27% 1 day and 23.46% 30 day share price returns suggest momentum is snapping back after a tougher stretch, even though the 1 year total shareholder return remains modestly negative and the 3 year total shareholder return...
NYSE:LAZ
NYSE:LAZCapital Markets

How New Senior Hires in Industrials Advisory at Lazard (LAZ) May Reshape Its Deal-Making Edge

Lazard, Inc. recently appointed Bill Young, Jean Greene and Paolo Battaglia as Managing Directors in its Global Industrials Group in New York, with Young leading Diversified Industrials and Greene rejoining after two decades at the firm. By adding senior bankers from Bank of America and Goldman Sachs, Lazard is reinforcing its advisory bench across diversified industrials, industrial technology and aerospace & defense. We’ll now examine how strengthening Lazard’s Global Industrials...
NYSE:ETN
NYSE:ETNElectrical

The Bull Case For Eaton (ETN) Could Change Following Boyd Thermal Deal And AI Data Center Push - Learn Why

Eaton Corporation recently reported a strong third quarter of 2025, highlighting record segment margins, robust demand in data centers, AI infrastructure, and electrification projects, and completion of the US$9.50 billion Boyd Thermal acquisition to expand its integrated AI power and liquid cooling solutions for hyperscale data centers. The company also raised its full-year adjusted EPS guidance to US$12.07, underscoring how higher-margin electrification and data center exposure are...
NasdaqGS:MRX
NasdaqGS:MRXCapital Markets

Do Marex Group’s (MRX) Accounting Allegations Raise Deeper Questions About Its Governance And Controls?

In recent months, several U.S. law firms have launched securities class actions against Marex Group plc, alleging that between May 16, 2024 and August 5, 2025 the company engaged in self-dealing over-the-counter trades and issued unreliable financial statements involving subsidiaries and related parties. The core allegation is that Marex’s reported cash flows, and the revenues, assets, and profits of its Market Making segment, were inflated through off-book intercompany transactions,...
NasdaqGS:ACLX
NasdaqGS:ACLXBiotechs

Arcellx (ACLX) Valuation Check After Strong Phase 2 iMMagine-1 Results for Anito-cel in Multiple Myeloma

Arcellx (ACLX) just put fresh clinical data on the table, and it is the kind investors tend to pay attention to. The company reported pivotal Phase 2 results for its multiple myeloma CAR T, anito cel. See our latest analysis for Arcellx. The upbeat iMMagine 1 readout has arrived after a choppy stretch, with the stock’s 30 day share price return still negative even as the 90 day move turns positive and three year total shareholder returns remain very strong. This hints that momentum may be...
NYSE:GOLD
NYSE:GOLDRetail Distributors

Gold.com (GOLD): Assessing Valuation After Rebrand From A-Mark Precious Metals and NYSE Ticker Change

Gold.com (GOLD) just completed a straightforward rebrand, changing its name from A-Mark Precious Metals and adopting the GOLD ticker on the NYSE, a move that naturally has investors taking a closer look. See our latest analysis for Gold.com. The rebrand comes after Gold.com was dropped from the Nasdaq Composite Index and shifted to the GOLD ticker on the NYSE, with a roughly 20 percent 1 month share price return suggesting fresh momentum despite a modest 1 year total shareholder return. If...
NasdaqGS:DIOD
NasdaqGS:DIODSemiconductor

Is Diodes (DIOD) Quietly Repositioning Itself as a Higher‑Value Automotive Power Management Specialist?

Earlier this month, Diodes Incorporated launched the AP61406Q, a 5.5V, 4A automotive‑compliant synchronous buck converter with an I2C 3.0 interface, targeting compact, high‑efficiency point‑of‑load applications in infotainment, instrument clusters, telematics, and ADAS. The device’s programmable power modes, frequency and current settings, plus EMI‑reducing gate driver design, highlight Diodes’ push into higher‑value automotive power management solutions. Next, we’ll examine how this highly...
NYSE:GME
NYSE:GMESpecialty Retail

How Investors Are Reacting To GameStop (GME) Q3 Earnings And “Trade Anything Day” Collectibles Push

GameStop Corp. recently confirmed it will report third-quarter 2025 results after the market close on December 9, alongside launching a “Trade Anything Day” promotion to support its collectibles business. The company’s renewed focus on collectibles, coupled with supportive commentary from a high-profile shareholder, is reshaping how investors view its core retail and engagement model. With recent gains in place, we’ll explore how the upcoming earnings release and the “Trade Anything Day”...
NasdaqGS:WTFC
NasdaqGS:WTFCBanks

Wintrust Financial (WTFC): Assessing Valuation After Recent Outperformance in Regional Bank Stocks

Wintrust Financial (WTFC) has quietly outperformed many regional peers this month, with the stock gaining about 5% as investors lean into its steady loan growth and improving profitability trends. See our latest analysis for Wintrust Financial. That latest move builds on a solid year to date, with a roughly 11% year to date share price return and a powerful 3 year total shareholder return of about 74%, suggesting momentum is still very much intact as investors reassess regional bank risk. If...
NasdaqGS:FIVE
NasdaqGS:FIVESpecialty Retail

Five Below (FIVE): Reassessing Valuation After Strong Q3 Beat and Upgraded Full-Year Guidance

Five Below (FIVE) just delivered a quarter that checked two big investor boxes at once: upside earnings and a guidance hike. Sales ran ahead of forecasts, and management responded by lifting full year expectations. See our latest analysis for Five Below. The market has been quick to reward that execution, with a roughly 22% 3 month share price return and a 76% year to date share price return at the latest close of $174.62. However, the 3 year total shareholder return is still slightly...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

Is GSK’s Exit and IDE034’s FDA Green Light Reframing the Investment Case For IDEAYA Biosciences (IDYA)?

In early December 2025, GSK notified IDEAYA Biosciences that it will terminate their 2020 collaboration, returning the Werner Helicase (IDE275) and Pol Theta (IDE705) programs, while IDEAYA also secured FDA clearance to begin a Phase 1 trial of its bispecific B7H3/PTK7 ADC IDE034 for multiple solid tumors in 2026. This combination of a major partnership unwind and the advancement of a potentially first-in-class oncology asset highlights IDEAYA’s increasing control over its pipeline and its...
NasdaqGS:FANG
NasdaqGS:FANGOil and Gas

Assessing Diamondback Energy (FANG) Valuation After Morgan Stanley’s Endorsement and New Capital Return Moves

Morgan Stanley is doubling down on its positive view of Diamondback Energy (FANG), pointing to its low cost Permian wells, rising free cash flow, and a capital plan that leans heavily toward shareholder payouts. See our latest analysis for Diamondback Energy. That backdrop helps explain why, even with the latest share price at $157.52, Diamondback’s 30 day share price return of 9.66% and 90 day gain of 15.58% suggest momentum is rebuilding. At the same time, a 5 year total shareholder return...